UNSPSC 51442501: Mangafodipir

This classification denotes a contrast media C22H26N4O14P2.H+.Mn.3Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 129FW80TG4, chemically known as mangafodipir trisodium, anhydrous, but more generally known as mangafodipir trisodium, which bears U.S. National Institutes of Health Compound Identifier 160036. European Medicines Agency schedules SUB12529MIGin its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12529MIG. Most nations schedule mangafodipir trisodium under HS 29333999 and SITC 51574.

Mangafodipir trisodium bears US NLM identifiers UMLS ID C0067297 and NCI Concept Code C66053. SMILES: As of Q4 2014, MANGAFODIPIR TRISODIUM remains the US FDA Preferred Term for this commodity.

UNSPSC 51442501 Mangafodipir, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The two recent opportunities posted under this code involve X-ray system maintenance services (Broward County Aviation Department RFI, June 25, 2026) and copper sulfate supply (Pasco County RFQ, June 3, 2026) — neither of which relates to mangafodipir, a contrast agent pharmaceutical. The code appears to be misapplied in both cases, and the source does not support identifying what state and local governments actually buy under this Commodity when properly classified.

No decision-relevant procurement activity under the correct scope of UNSPSC 51442501 is evident from the source. Business development professionals should treat this code as currently inactive for state and local contract pursuit and verify any future opportunities' UNSPSC coding before investing qualification effort.